Summary of Purpose
Evaluation of 2 doses of rivaroxaban (10 and 15 mg) compared to dual anti platelet therapy (aspirin+clopidogrel) after left atrial appendage closure. The patients will be assessed at 10 and 90 days: central laboratory hemostasis analysis and clinical events assessment.Read More →
The following dates are available for this trial. Trial information last updated on 19 September 2017.
|13 Sep 2017||11 Aug 2017||23 Sep 2018||23 Dec 2018||1 Sep 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Gilles MONTALESCOT, MD, PhD
Gilles.firstname.lastname@example.org +331 42163006